A Novel Bacterium, Butyricimonas virosa, Preventing HFD-Induced Diabetes and Metabolic Disorders in Mice via GLP-1 Receptor

Autor: Lee, Heetae, An, Jinho, Kim, Jiyeon, Choi, Dohyun, Song, Youngcheon, Lee, Chong-Kil, Kong, Hyunseok, Kim, Sang Bum, Kim, Kyungjae

Publikováno v: Frontiers in Microbiology. 13

Knowledge of the impact of the gut microbiota on human health has increased, and modulation of the bacterial community is now considered a therapeutic target for various diseases. Certain novel bacterial species have probiotic properties associated w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6b657addc053f12cd33446dbb1b67cd
https://doi.org/10.3389/fmicb.2022.858192

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Validation of "sasLM," an R package for linear models with type III sum of squares.

Autor: Sunwoo J; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Kim H; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Choi D; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea., Bae KS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Publikováno v: Translational and clinical pharmacology [Transl Clin Pharmacol] 2020 Jun; Vol. 28 (2), pp. 83-91. Date of Electronic Publication: 2020 Jun 24.